CAS 58962-34-8|6-Oxoprostaglandin F1α
Introduction：Basic information about CAS 58962-34-8|6-Oxoprostaglandin F1α, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 6-Oxoprostaglandin F1α | ||
|---|---|---|---|
| CAS Number | 58962-34-8 | Molecular Weight | 370.480 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 575.3±50.0 °C at 760 mmHg |
| Molecular Formula | C20H34O6 | Melting Point | / |
| MSDS | / | Flash Point | 315.8±26.6 °C |
Names
| Name | 6-oxo-prostaglandin F1α |
|---|---|
| Synonym | More Synonyms |
6-Oxoprostaglandin F1α BiologicalActivity
| Description | 6-keto Prostaglandin F1α is an endogenous metabolite present in Cerebrospinal_Fluid, Urine and Blood that can be used for the research of Meningitis, Rheumatoid Arthritis and Cardiopulmonary Resuscitation[1][2][3][4]. |
|---|---|
| Related Catalog | Research Areas >>Inflammation/Immunology |
| Target | Human Endogenous Metabolite |
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
| References | [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [2]. Westcott JY, et al. Eicosanoids in human ventricular cerebrospinal fluid following severe brain injury. Prostaglandins. 1987 Dec;34(6):877-87. [3]. Laitinen O, et al. Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. Clin Rheumatol. 1983 Dec;2(4):401-6. [4]. Strohmenger HU, et al. Concentrations of prolactin and prostaglandins during and after cardiopulmonary resuscitation. Crit Care Med. 1995 Aug;23(8):1347-55. |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 575.3±50.0 °C at 760 mmHg |
| Molecular Formula | C20H34O6 |
| Molecular Weight | 370.480 |
| Flash Point | 315.8±26.6 °C |
| Exact Mass | 370.235535 |
| PSA | 115.06000 |
| LogP | 0.93 |
| Vapour Pressure | 0.0±3.6 mmHg at 25°C |
| Index of Refraction | 1.561 |
| InChIKey | KFGOFTHODYBSGM-ZUNNJUQCSA-N |
| SMILES | CCCCCC(O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O |
Safety Information
| Safety Phrases | S22-S24/25 |
|---|---|
| RIDADR | NONH for all modes of transport |
Synonyms
| Prost-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9α,11α,13E,15S)- |
| 6-Oxoprostaglandin F1α |
| 6-KETO-PROSTAGLANDIN F1ALPHA |
| 6-OXO-9ALPHA,11ALPHA,15S-TRIHYDROXY-PROST-13E-EN-1-OIC ACID |
| Prosta-13-en-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9α,11α,13E,15S)- |
| 6-oxo-prostaglandin F1alpha |
| 6-Oxoprostaglandin F1alpha |
| 6-KETOPROSTAGLANDIN F1A |
| (9α,11α,13E,15S)-9,11,15-Trihydroxy-6-oxoprost-13-en-1-oic acid |
| 6-Keto Prostaglandin |
| 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoic acid |
